🔗 Share this article

Treasury head Reeves has revealed she is planning "specific action to address household expense issues" in the upcoming Budget.

Speaking to the BBC, she noted that curbing inflation is a shared responsibility of both the government and the central bank.

The UK's inflation rate is forecast to be the most elevated among the G7 industrialized countries this year and the following year.

Potential Energy Cost Interventions

Sources suggest the administration could intervene to bring down energy bills, such as by reducing the present 5% rate of VAT charged on energy supplies.

Another option is to cut some of the regulatory levies presently added to household expenses.

Fiscal Constraints and Expert Expectations

The administration will obtain the latest assessment from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much room there is for these actions.

The view from the majority of experts is that the Chancellor will have to announce higher taxes or expenditure reductions in order to meet her voluntary debt limits.

Previously on Thursday, calculations indicated there was a £22bn gap for the chancellor to address, which is at the lower end of forecasts.

"It is a joint task between the central bank and the administration to continue tackling some of the causes of inflation," the Chancellor told reporters in Washington, at the conferences of the International Monetary Fund and global financial institution.

Tax Pledges and Global Concerns

While a great deal of the focus has been on expected tax increases, the Treasury chief said the latest information from the fiscal watchdog had not altered her pledge to campaign commitments not to raise rates on income tax, sales tax or social security contributions.

She blamed an "uncertain world" with growing geopolitical and commercial issues for the fiscal tax moves, likely to be directed on those "wealthiest."

International Trade Disputes

Addressing apprehensions about the UK's economic relations with China she said: "Our security interests always come first."

Recent statement by China to tighten trade restrictions on critical minerals and other materials that are crucial for advanced tech production led US President Donald Trump to propose an further 100% tariff on goods from the Asian country, increasing the possibility of an all-out commercial conflict between the two largest economies.

The American finance chief called the Chinese action "economic coercion" and "a global supply chain power grab."

Inquired about accepting the American proposal to join its dispute with the Asian nation, Reeves said she was "deeply worried" by Chinese actions and called on the Beijing authorities "to avoid restrictions and restrict access."

She said the action was "bad for the world economy and creates additional headwinds."

"In my view there are fields where we must challenge China, but there are also valuable opportunities to sell into Chinese markets, including financial services and other areas of the economy. We've got to maintain that balance appropriate."

The chancellor also affirmed she was collaborating with G7 counterparts "regarding our own critical minerals approach, so that we are more independent."

NHS Medicine Pricing and Investment

Reeves also acknowledged that the price the National Health Service pays for medicines could go up as a result of ongoing discussions with the US government and its drugs companies, in return for reduced taxes and capital.

A number of the biggest global drug companies have said recently that they are either halting or canceling operations in the United Kingdom, with several attributing the insufficient payments they are getting.

Last month, the government science advisor said the cost the NHS spends on medicines would need to rise to halt companies and drug research funding departing from the UK.

Reeves stated to media: "It has been observed because of the cost structure, that medical research, recent pharmaceuticals have not been offered in the UK in the way that they are in other EU nations."

"The objective is to guarantee that people receiving treatment from the National Health Service are able to obtain the best life-saving medicines in the globe. And so we are reviewing these issues, and... aiming to secure additional investment into the UK."